Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04892849
What this trial is testing

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Who this might be right for
HNSCCNSCLCEsophageal Cancer+4 more
University of Erlangen-Nürnberg Medical School 200
Testing effectiveness (Phase 2)Looking for participantsNCT05177133
What this trial is testing

Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 25
Early research (Phase 1)UnknownNCT05317325
What this trial is testing

A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan University 20
Early research (Phase 1)Study completedNCT01843725
What this trial is testing

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

Who this might be right for
Metastatic Colorectal CancersMetastatic Gastric CancersMetastatic Oesophageal Cancers+3 more
Jules Bordet Institute 37
Testing effectiveness (Phase 2)Looking for participantsNCT04278287
What this trial is testing

Chemoradiotherapy in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyAlbumin-bound Paxlitaxel+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 105
Early research (Phase 1)Active Not RecruitingNCT04391049
What this trial is testing

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Who this might be right for
Advanced Esophageal AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage II Esophageal Adenocarcinoma AJCC v8+30 more
NRG Oncology 16
Not applicableStudy completedNCT03228147
What this trial is testing

Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment

Who this might be right for
EsophagitisMalignant NeoplasmMucositis
Rutgers, The State University of New Jersey 30
Not applicableStudy completedNCT03165344
What this trial is testing

Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma

Who this might be right for
Esophageal Stenosis Acquired
Peking University Third Hospital 66
Not applicableStudy completedNCT05611658
What this trial is testing

Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT

Who this might be right for
Esophageal Cancer
Institute of Oncology Ljubljana 23
Not applicableStudy completedNCT05604664
What this trial is testing

Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc

Who this might be right for
Esophageal Cancer
Yongtao Han 1,727
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Post-approval studies (Phase 4)UnknownNCT03642093
What this trial is testing

HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery

Who this might be right for
Pancreatic CancerEsophageal CancerGastric Cancer
Siobhan Trotter 60
Testing effectiveness (Phase 2)UnknownNCT04286958
What this trial is testing

Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC

Who this might be right for
Esophageal Cancer
Hebei Medical University Fourth Hospital 40
Not applicableStudy completedNCT01937793
What this trial is testing

Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy

Who this might be right for
Nasopharyngeal CancerDysphagia
National Taiwan University Hospital 16
Early research (Phase 1)Study completedNCT05411133
What this trial is testing

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Who this might be right for
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd 33
Not applicableLooking for participantsNCT04734821
What this trial is testing

Fluorescence Image Guided Foregut Surgery

Who this might be right for
Esophageal CancerGastric Cancer
IHU Strasbourg 60
Not applicableLooking for participantsNCT07301814
What this trial is testing

Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

Who this might be right for
Gastric CancerPancreatic CancerCholangiocarcinoma Cancer+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 56
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Not applicableStudy completedNCT07722819
What this trial is testing

ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance

Who this might be right for
P53 Mutation in Esophageal Cancer
Ling Zhiqiang 300
Early research (Phase 1)Study completedNCT02642809
What this trial is testing

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Who this might be right for
Esophageal CancerCancer of the Esophagus
Washington University School of Medicine 16
Next Page